Quantinno Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.9M Buy
351,692
+33,006
+10% +$1.56M 0.02% 765
2025
Q4
$16.2M Buy
318,686
+51,390
+19% +$2.63M 0.03% 599
2025
Q3
$14.8M Buy
267,296
+21,856
+9% +$1.28M 0.04% 505
2025
Q2
$16.9M Buy
245,440
+8,393
+4% +$571K 0.07% 317
2025
Q1
$16.5M Buy
237,047
+25,181
+12% +$2.08M 0.11% 198
2024
Q4
$18.2M Buy
211,866
+9,885
+5% +$1.07M 0.18% 73
2024
Q3
$24M Buy
201,981
+16,995
+9% +$2.27M 0.31% 42
2024
Q2
$26.4M Buy
184,986
+64,769
+54% +$8.58M 0.47% 27
2024
Q1
$15.4M Buy
120,217
+3,793
+3% +$452K 0.34% 43
2023
Q4
$12M Sell
116,424
-4,985
-4% -$493K 0.42% 28
2023
Q3
$11M Buy
121,409
+80,195
+195% +$7.06M 0.5% 25
2023
Q2
$3.33M Buy
41,214
+4,386
+12% +$358K 0.19% 90
2023
Q1
$2.93M Buy
36,828
+6,624
+22% +$470K 0.19% 99
2022
Q4
$2.04M Buy
30,204
+13,944
+86% +$818K 0.15% 183
2022
Q3
$810K Buy
16,260
+11,706
+257% +$627K 0.1% 251
2022
Q2
$254K Buy
+4,554
New +$253K 0.04% 506

Other funds holding NVO

Quantinno Capital Management's NVO Position: Q1 2026 in Review

Quantinno Capital Management increased its Novo Nordisk (NVO) stake by 10% in Q1 2026, buying an estimated $1.56M and bringing the position to 351,692 shares worth $12.9M. The position accounts for 0.02% of the portfolio, ranked #765.

Quantinno Capital Management first reported a position in NVO in Q2 2022 and has held it in 16 quarters since. The position peaked at $26.4M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Quantinno Capital Management held 351,692 shares of Novo Nordisk worth $12.9M as of Q1 2026.
  • Quantinno Capital Management bought 33,006 Novo Nordisk shares in Q1 2026, an estimated $1.56M.
  • Novo Nordisk made up 0.02% of Quantinno Capital Management's portfolio in Q1 2026, its #765 holding.
  • Quantinno Capital Management first reported a position in Novo Nordisk in Q2 2022 and has held it in 16 quarters since.
  • Quantinno Capital Management's Novo Nordisk position peaked at $26.4M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.